BackPropanc Biopharma Overview

Propanc Biopharma Current Cash

Track Propanc Biopharma's current cash ($440K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$443702.00
↑ 774.12% YoYΔ $392942.00 vs prior year quarter

Peer trimmed avg / median

Loading

Propanc Biopharma Current Cash History

Loading

Propanc Biopharma vs. peers: Current Cash Comparison

Loading

Propanc Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Propanc Biopharma (PPCB) FAQ

Propanc Biopharma (PPCB) currently reports a current cash of $440K as of March 2026. That compares with $51K in the prior-year period — up 774.1% year over year. Use the charts on this page to explore Propanc Biopharma's current cash history and peer comparisons.

Propanc Biopharma's current cash increased from $51K to $440K — a 774.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Propanc Biopharma reported $440K in current cash as of March 2026. That compares with $51K in the prior-year period — up 774.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $440K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Propanc Biopharma, and consider following PPCB for alerts when major investors trade the stock.

Propanc Biopharma is classified in the Healthcare sector. On current cash, it currently shows $440K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PPCB with unrelated industries.